| P2093 | author name string | A D Wechalekar | |
| | C Whelan | |
| P2860 | cites work | Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients | Q58029880 |
| | A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis | Q61657837 |
| | Systemic amyloidosis | Q30251986 |
| | Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. | Q30493710 |
| | Cdc42 regulates neutrophil migration via crosstalk between WASp, CD11b, and microtubules | Q30527782 |
| | A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis | Q33718805 |
| | First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction | Q33795363 |
| | Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component | Q34485172 |
| | Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis | Q35623662 |
| | Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis | Q35886289 |
| | Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish | Q37054932 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | doxycycline | Q422442 |
| P304 | page(s) | e546 | |
| P577 | publication date | 2017-03-24 | |
| P1433 | published in | Blood Cancer Journal | Q2464036 |
| P1476 | title | Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis | |
| P478 | volume | 7 | |